South Korea’s cannabidiol sector has experienced cautious but steady progression amid a traditionally conservative regulatory environment. Historically, cannabis use was largely prohibited, and the cultural stigma surrounding it remained strong. However, following the Narcotics Control Act amendment in 2018, which allowed for the import and use of hemp-derived products containing less than 0.3% THC, the market slowly began to open up. Early commercialization efforts were led by companies such as MediGreen and Purpharma, which introduced CBD isolates primarily for medicinal and cosmetic applications. Extraction techniques have seen improvements with the adoption of CO2 extraction, favored for producing high-purity CBD without harmful residues, with firms like KACA (Korea Agro-Fisheries & Food Trade Corporation) supporting research into refined methods. Full-spectrum CBD remains limited in availability due to stringent THC restrictions, but isolate products dominate retail shelves.

Packaging innovations include tamper-evident seals and dosage-specific formats designed by companies like Kolmar Korea, aiming to build consumer trust and comply with local safety regulations. Regulatory frameworks in South Korea align with global trends but remain more restrictive compared to North America and Europe, with the Ministry of Food and Drug Safety maintaining strict controls on CBD in food and beverages, only approving it in topical and pharmaceutical forms so far. Third-party certification, including GMP compliance, is becoming a crucial aspect for domestic producers to reassure consumers about product safety, as shown by the quality assurance programs led by Korea Testing & Research Institute. While research on long-term health impacts is ongoing through institutions such as Seoul National University, regulatory delays have slowed widespread adoption, particularly for edible CBD products. According to the research report, "South Korea Cannabidiol Market Research Report, 2030," published by Actual Market Research, the South Korea Cannabidiol market is anticipated to add to more than USD 120 Million by 2025–30.The South Korean cannabidiol marketplace is characterized by a dynamic interplay between emerging companies and strict regulatory oversight. Leading domestic brands such as MediGreen and Kwangdong Pharmaceutical have been pivotal in establishing a presence both online and through select pharmacy chains like Olive Young and Watsons. E-commerce platforms like Coupang and 11st have fueled product accessibility, especially among younger demographics who actively follow influencers promoting wellness-oriented lifestyles.

The retail landscape has seen physical stores adopting CBD-infused skincare and health supplements as part of broader wellness offerings. Multi-channel marketing strategies have been essential in a climate where advertising CBD faces limitations imposed by platforms such as Naver and Kakao. Education-based campaigns spearheaded by medical professionals from Korea University’s College of Medicine have worked to reduce confusion between CBD and THC and to combat residual stigma. Supply chains remain vulnerable due to heavy reliance on imported hemp from the US and EU, with logistics firms like CJ Logistics navigating complex customs regulations. Product innovation is on the rise, with brands like The Lab using nanoemulsion technology to boost absorption and consumer satisfaction. Automation and large-scale facilities are still nascent but expanding, as seen with investments by Purpharma to scale production capabilities.

Industry consolidation is emerging, highlighted by strategic partnerships between pharmaceutical giants such as Hanmi Pharmaceutical and CBD startups to accelerate product development. Collaborations with hospitals including Asan Medical Center help bolster clinical credibility. Ethical sourcing and organic hemp cultivation initiatives are increasingly emphasized by companies like Korea Hemp, aligning with global sustainability trends. In South Korea, oils and tinctures are becoming increasingly popular due to their versatility and ease of use, especially among the wellness-focused population in cities like Seoul and Busan. Many consumers prefer these products as a convenient way to incorporate cannabidiol into their daily routine. Topicals and skincare products containing CBD are increasingly found in beauty stores throughout South Korea, with products like creams, serums, and lotions becoming staples in the country’s beauty-conscious market.

With Seoul being a hub for skincare innovation, many local brands have begun incorporating CBD into their formulas, promoting it for its anti-inflammatory and anti-aging properties. CBD oils are sold in various concentrations and are commonly used by individuals seeking relief from stress and insomnia. The capsules and softgels segment is also gaining traction as South Korean consumers continue to show a preference for precise, measured doses of CBD. Products like these are particularly popular among those who want a discreet and hassle-free option for cannabidiol consumption, and they can be easily found in local pharmacies and wellness stores. Meanwhile, the market for gummies and confectionery infused with CBD is growing rapidly, particularly among younger demographics in South Korea’s metropolitan areas, such as Gangnam and Itaewon. These edibles offer a fun, tasty way to experience the benefits of cannabidiol, and their popularity is boosted by their appeal to those who are new to CBD.

Vape products are less common in South Korea due to strict regulations on vaping, but there is a niche market that seeks faster-acting forms of CBD. The other CBD products, including beverages and snacks, are slowly being introduced in health-conscious communities, especially in cities known for their wellness trends.The wellness and personal use segment is the major driver of South Korea's cannabidiol market, particularly in urban areas like Seoul, where a strong wellness culture prevails. Many individuals are increasingly turning to CBD as part of a holistic approach to well-being, with oils, tinctures, and capsules being popular products used to reduce anxiety, improve sleep, and promote overall relaxation. In addition, the nutraceuticals and supplements sector is expanding rapidly in South Korea as more people seek natural alternatives for managing chronic health conditions. CBD is being marketed as a potent supplement for managing pain, inflammation, and stress, making it particularly appealing to health-conscious individuals. The pet care market for CBD is still emerging in South Korea but is expected to grow, as pet owners are becoming more aware of the potential benefits of cannabidiol for pets, particularly for managing anxiety and pain in older animals.

Many South Korean pet owners in urban centers like Seoul are beginning to seek out CBD products for their dogs and cats, which are marketed as natural supplements to improve pets' quality of life. In the cosmetics and skincare sector, CBD-infused products are increasingly popular in South Korea's beauty industry. Known for its focus on skincare innovation, Seoul is home to numerous brands that use CBD for its purported anti-inflammatory and antioxidant properties. Pharmaceuticals also play an essential role in the market, as South Korea’s medical community begins exploring CBD’s potential therapeutic applications. Research into its use for epilepsy and chronic pain is underway at institutions like Seoul National University. Food and beverages containing CBD are gaining traction, particularly in South Korea's health-conscious circles, where CBD-infused teas, coffees, and snacks are slowly becoming more popular.In South Korea, marijuana-derived CBD is strictly regulated and remains difficult to access due to the country’s rigid drug laws, which have historically been conservative regarding cannabis use.

However, there have been some recent changes in legislation, allowing for the medical use of CBD products derived from marijuana under specific circumstances. This has opened a small yet growing market for marijuana-based CBD, especially for medical conditions like epilepsy, under strict prescription guidelines. Hemp-derived CBD, on the other hand, is a more widely accepted source in South Korea. The country has been importing hemp-based CBD products primarily from countries where hemp cultivation is legal and regulated, such as the United States and European nations like Switzerland. Hemp-derived CBD products are easier to market and distribute because they comply with South Korea's stringent regulations, which prohibit THC content above a certain level. As a result, most of the CBD products available in South Korea, including oils, capsules, and topicals, are derived from hemp.

South Korean authorities have established clear guidelines for the sale of hemp-based CBD products, allowing for the growth of a well-regulated market that focuses on wellness, skincare, and supplements. The growing interest in hemp-derived CBD is also supported by the country’s agricultural sector, with discussions underway about the potential for domestic hemp farming in the future, particularly in areas with suitable climates like Jeju Island. This would allow South Korea to develop its own supply of CBD, reducing dependence on imports and boosting the local economy while adhering to international standards.Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cannabidiol Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Form• Oils & Tinctures• Capsules & Softgels• Gummies & Confectionery• Topicals / Skin Care• Vape Products• OthersBy End Use• Wellness & Personal Use• Nutraceuticals & Supplements• Pet Care• Cosmetics & Skin Care• Pharmaceuticals• Food & BeveragesBy Source• Marijuana• Hemp.